Led by double-digit growth in its India formulations business, especially specialty drugs, Vadodara-based Alembic Pharmaceuticals Ltd (APL) posted a 24.92 per cent rise in its consolidated net profit for the third quarter of financial year 2020-21. The company saw its consolidated profit after tax (PAT) stand at Rs 292.57 crore in Q3 of FY21, up from Rs 234.19 crore in the said quarter last year. APL s consolidated total income on the other hand grew by 8.87 per cent in the said quarter at Rs 1316.86 crore, up from Rs 1209.54 crore in Q3 of previous FY 20. According to Shaunak Amin, managing director of APL, while the third quarter saw some moderation in US business after several quarters of double digit topline due to multiple factors, it was the active pharmaceutical ingredients (APIs) and India formulations business including specialty drugs that led the growth.
Alembic Pharmaceuticals Ltd board to consider quarterly results on Jan 19, 2021
Posted On: 2021-01-07 07:33:30 (Time Zone: Arizona, USA)
A Meeting of Board of Directors of Alembic Pharmaceuticals Ltd will be held on Tuesday, 19th January, 2021, to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended 31st December, 2020.
The trading window for dealing in securities of the Company which was closed from 1st January, 2021, will re-open 48 hours after the declaration of the financial results.
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.1068.95 as compared to the previous close of Rs. 1069.95. The total number of shares traded during the day was 9027 in over 705 trades.
Healthcare stocks were trading in red, with the S&P BSE Healthcare index decreasing 125.64 points or 0.57% at 21981.04 at 13:48 IST. Among the components of the S&P BSE Healthcare index, Vimta Labs Ltd (down 4.1%), Gufic BioSciences Ltd (down 3.55%),Sun Pharma Advanced Research Company Ltd (down 3.47%),Lupin Ltd (down 3.37%),Syngene International Ltd (down 2.58%), were the top losers. Among the other losers were Take Solutions Ltd (down 2.56%), Strides Pharma Science Ltd (down 2.4%), Alembic Pharmaceuticals Ltd (down 2.28%), Alembic Ltd (down 1.92%), and Piramal Enterprises Ltd (down 1.87%). On the other hand, Shalby Ltd (up 4.36%), Albert David Ltd (up 4.03%), and Fortis Healthcare Ltd (up 3.12%) turned up.
At 13:48 IST, the S&P BSE Sensex was down 277.53 or 0.57% at 48160.25.
Healthcare stocks were trading with losses, with the S&P BSE Healthcare index decreasing 95.91 points or 0.44% at 21486.84 at 13:47 IST. Among the components of the S&P BSE Healthcare index, Neuland Laboratories Ltd (down 2.61%), Unichem Laboratories Ltd (down 2.43%),Marksans Pharma Ltd (down 2.33%),Alembic Pharmaceuticals Ltd (down 2.15%),Fortis Healthcare Ltd (down 1.98%), were the top losers. Among the other losers were Take Solutions Ltd (down 1.94%), Shilpa Medicare Ltd (down 1.9%), Granules India Ltd (down 1.84%), IOL Chemicals & Pharmaceuticals Ltd (down 1.71%), and Strides Pharma Science Ltd (down 1.7%). On the other hand, Lincoln Pharmaceuticals Ltd (up 4.61%), Bliss GVS Pharma Ltd (up 3.52%), and Astrazeneca Pharma India Ltd (up 2.27%) turned up.
Healthcare stocks slide business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.